Dermapharm Holding SE (XTER:DMP) EPS (Basic) : €1.92 (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE EPS (Basic)?

Dermapharm Holding SE's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was €0.62. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was €1.92.

Dermapharm Holding SE's EPS (Diluted) for the three months ended in Mar. 2025 was €0.62. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €1.92.

Dermapharm Holding SE's EPS without NRI for the three months ended in Mar. 2025 was €0.62. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.92.

During the past 12 months, Dermapharm Holding SE's average EPS without NRIGrowth Rate was 82.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -17.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Dermapharm Holding SE's highest 3-Year average EPS without NRI Growth Rate was 38.90% per year. The lowest was -17.70% per year. And the median was 6.15% per year.

Dermapharm Holding SE EPS (Basic) Historical Data

The historical data trend for Dermapharm Holding SE's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE EPS (Basic) Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

1.59

3.89

2.49

1.16

2.11

Dermapharm Holding SE Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.81	0.32	0.60	0.38	0.62

Dermapharm Holding SE EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Dermapharm Holding SE's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(113.787	-	0)	/	53.840
	=	2.11

Dermapharm Holding SE's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(33.405	-	0)	/	53.879
	=	0.62

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.92

Dermapharm Holding SE (XTER:DMP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Dermapharm Holding SE EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (XTER:DMP) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

DMPHF:USA 0A5J:UK DMP:Austria

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Executives

Wilhelm Beier	Supervisory Board
Dr. Hans-georg Feldmeier	Board of Directors
Christof Dreibholz	Board of Directors
Lothar Lanz	Supervisory Board
Anja Schorn	Board Member Themis Beteiligungs-AG
Hilde Neumeyer	Board of Directors

Dermapharm Holding SE Headlines

No Headlines